Table 3 Immunophenotypic characteristics of hairy cell leukemia-variant

From: Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience

Marker

Positive /Total cases studied

Bright

Dim/Partial

Negative

Immunohistochemistry

  CD20

21/21 (100%)

21 (100%)

—

—

  PAX-5

13/13 (100%)

13 (100%)

—

—

  DBA.44

14/15 (93%)

14 (93%)

—

1 (7%)

  Annexin-1

0/18 (0%)

—

—

18 (100%)

  Cyclin D1

0/10 (0%)

—

—

10 (100%)

  BRAF

0/8 (0%)

—

—

8 (100%)

Flow Cytometry

  CD19

22/22(100%)

22 (100%)

—

—

  CD20

21/21(100%)

21 (100%)

—

—

  CD22

18/18 (100%)

18 (100%)

—

—

  CD79b

17/17 (100%)

13 (77%)

4 (23%)

—

  CD11c

21/21 (100%)

18 (86%)

3 (14%)

—

  CD103

21/22(95%)

19 (86%)

2 (9%)

1 (5%)

  CD25

3/22(14%)

—

3 (14%)

19 (86%)

  CD5

0/22 (0%)

—

—

22 (100%)

  CD10

0/22 (0%)

—

—

22 (100%)

  CD23

0/16 (0%)

—

—

16 (100%)

  CD38

0/10 (0%)

—

—

10 (100%)

  CD43

0/10 (0%)

—

—

10 (100%)

  CD52

8/8 (100%)

8(100%)

—

—

  CD200

7/12 (58%)

—

7 (58%)

5 (42%)

  FMC7

10/11 (91%)

10 (91%)

—

1 (9%)

  CD123

1/1 (100%)

1/1 (100%)

—

—

 Surface light chains Kappa/lambda

20/22 (91%) 10/10

12/19 (63%)

7/19 (37%)

2/22 (9%)